Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update

NEXT STORY
Atossa Therapeutics Announces Pricing of $50.0 Million Registered Direct Offering Priced At-The-Market
PREV STORY
Amolyt Pharma Presents First Clinical Data for AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The Ensign Group Completes Sale of its Urgent Care Assets

MISSION VIEJO, Calif., Dec. 14, 2016 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq:ENSG), ...

author_avatar
NASDAQ Market News

Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016

PLYMOUTH MEETING, Pa., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA® for H. pylori Infection

Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with ...

author_avatar
NASDAQ Market News